Bio-TechneTECHEarnings & Financial Report
Nasdaq · Health Care · Life Sciences Tools & Services
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| The Vanguard Group | 11.53% | 18.2M | — | 2024-02-13 |
| BlackRock, Inc. | 8.70% | 13.8M | flat | 2024-11-08 |
| T. ROWE PRICE ASSOCIATES, INC. | 5.90% | 9.4M | — | 2024-11-14 |
Insider Transactions
Net 90d: +$0 · buys $0 / sells $0Range:
Action:
Role:
| Insider | Role | Action | ||||
|---|---|---|---|---|---|---|
| 2026-04-22 | James Hippel | CFO | Option exercise | 62.0K | $0.00 | $0 |
| 2026-04-22 | Kim Kelderman | Chief Executive Officer | Option exercise | 11.3K | $0.00 | $0 |
| 2026-04-14 | Kim Kelderman | Chief Executive Officer | Option exercise | 36.5K | $0.00 | $0 |
| 2026-04-03 | Shane Bohnen | SVP - General Counsel | Option exercise | 2.3K | $0.00 | $0 |
1–4 of 4